What are immunoglobulins?
‘Immunoglobulins’ is another name for antibodies. Antibodies are proteins that your immune system makes in response to infection or vaccination. They help fight or prevent infections by sticking to the surface of germs. This can:
- stop the germ infecting you
- act like a flag to tell immune cells to kill the germ
- activate substances that kill the germ.
Immune cells called B cells (B lymphocytes) usually make antibodies. If your B cells aren’t working properly, they might not make enough antibodies.
What is immunoglobulin replacement therapy?
Immunoglobulin replacement therapy is treatment that boosts your antibody levels when they are low. This can help you fight infection.
It is different from the antibody therapy you might have as part of your treatment for lymphoma. That is made in a lab and specifically attacks the lymphoma cells.
Immunoglobulin replacement therapy uses natural antibodies collected from a large number of people who have donated their blood. Blood donors complete a medical questionnaire first to make sure they are suitable, and their blood is carefully screened for infections. It is then filtered and processed to separate out the antibodies.
Most people with lymphoma do not need immunoglobulin replacement therapy.
If your antibody levels are low, you might need regular antibiotic treatment to help prevent infections. For most people, this provides enough protection against infections and immunoglobulin replacement therapy isn’t necessary. You are only likely to need immunoglobulin replacement therapy if your antibody levels are low and you have had severe or repeated infections despite regular preventative antibiotic treatment.
This is most likely to affect people who:
- have chronic lymphocytic leukaemia (CLL)
- have B-cell non-Hodgkin lymphoma
- have Hodgkin lymphoma
- have had a donor (allogeneic) stem cell transplant
- have had CAR T-cell therapy
- have had treatment that destroys B cells (such as chemotherapy)
- have had treatment that lowers their number of B cells (such as rituximab).
People with other types of lymphoma might also occasionally need immunoglobulin replacement therapy. It is also sometimes used to treat other immune system problems, such as:
- Autoimmune haemolytic anaemia that hasn’t responded to other treatments. Autoimmune haemolytic anaemia is a shortage of red blood cells caused by your immune system attacking your own cells. It can affect some people with low-grade lymphoma.
- Immune thrombocytopenia that hasn’t responded to other treatments in people who are at risk of severe bleeding. Immune thrombocytopenia is a shortage of platelets caused by your immune system attacking your own cells. It affects around 1 in 10 people with CLL.
Before having immunoglobulin replacement therapy, you might have a ‘vaccine challenge’ test. This involves having a standard vaccination (usually the pneumococcal pneumonia jab) and then having a blood test a few weeks later to test how well your body has responded to it. This test helps your medical team decide whether or not you need immunoglobulin replacement therapy.
Most people have immunoglobulin replacement therapy as an outpatient. You might have it in one of two ways:
- Through a drip into a vein (intravenous immunoglobulin or IVIg): If you have IVIg, you have it every 3 to 4 weeks. You have the first few doses slowly to reduce the risk of side effects. It takes around 4 to 6 hours. You are advised not to drive yourself home after these first few sessions so make sure you make suitable transport arrangements. Later doses take around 2 to 3 hours.
- As a slow injection under your skin (subcutaneous immunoglobulin or SCIg): If you have SCIg, you usually have it every week, although some people have smaller doses more frequently. The injection usually goes into your thigh, tummy or upper arm. You have SCIg through a motorised syringe that gives the treatment at a steady rate. Depending on the dose you have, each treatment takes up to 2 hours. Some people are taught how to give the treatment themselves at home.
Depending on your individual circumstances, you might need long-term treatment. While you are on immunoglobulin replacement therapy, you should have regular blood tests to measure your level of antibodies. This makes sure you get the most appropriate dose for you.
Most people do not have many side effects. Side effects are usually mild and temporary. They are more common during your first few treatments. Your nurse monitors you carefully for side effects and you might be given medicines to prevent them. Serious side effects are very rare.
The most common side effects of immunoglobulin replacement therapy are:
- flu-like symptoms, such as fever or shivers
- headache or dizziness
- feeling sick or being sick
- low blood pressure
- lower back pain or joint pain.
If you feel unwell during or shortly after having immunoglobulin replacement therapy, tell the nurse straightaway. They can slow down or stop the infusion, or give you treatment to help.
If you have your treatment as a slow injection under your skin, you might develop soreness, swelling, itching or a rash where you had the injection. This usually gets better within 24 hours.
One of the main concerns people have about immunoglobulin replacement therapy is the possibility of passing an infection from the blood donors to the person receiving the treatment. The process of donor selection and the methods used to prepare the immunoglobulin product make this extremely unlikely.